-
Registrations and welcome coffeeJan. 29
-
S2 - Radiation
Jan. 29
-
S3 - Nursing 1: Sex-Specific Cardiovascular Risk Modifiers - Pregnancy, Menopause, and Aging
Jan. 29
-
S1 - YCC - Invisible Killers: Pollution, Noise & Climate Stress on the Heart?
Jan. 29
-
S4 - Keynote & Gold medal
Jan. 29
-
S5 - Nursing - 2 - Inside the Rhythm: Devices, Leads, and Daily Living
Jan. 29
-
Coffee break & best PosterJan. 29
-
S7 - Scientific symposium sponsored by AstraZeneca: Belgian Initiatives in Cardiovascular Care to improve the journey of patients with heart failure, hypertension, and cardiac amyloidosis
Jan. 29
-
S6 - BACTS & BSC Joint session
Jan. 29
-
S8 - Nursing - 3 - Circulatory Challenges: Managing Pressure, Clotting, and Cerebral Events
Jan. 29
More information soon
Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness analysis in Belgium
Christophe L. Dubois, MD, PhD.
Christophe Dubois was born on October 12, 1970, in Rocourt, Belgium. He is married with three
children. He received his MD from the Katholieke Universiteit of Leuven in 1995 with magna cum laude.
From 1995 to 1998, Prof. Dubois was a fellow in internal medicine at the Imelda Hospital of Bonheiden
and at the Gasthuisberg University Hospital of Leuven. From 1998 to 2001, he completed a fellowship
in cardiology at the Sint Jan Hospital of Genk and at the Gasthuisberg University Hospital of Leuven,
where he graduated as a cardiologist in 2001.
In 2001 Prof. Dubois joined the staff of the department of cardiovascular medicine of the Gasthuisberg
University Hospital. During his first years of practice he gained large experience in acute and
interventional cardiology. In 2003 he started fundamental research on the potential role of stem cells
in the regeneration of cardiac tissue following myocardial infarction, and received his PhD on this topic
in 2010. Simultaneously, he focused on complex coronary interventions in bifurcation lesions and the
left main coronary artery, and was site principal investigator of numerous clinical trials. In 2008 he set
up a percutaneous heart valve program together with his surgical colleagues. To date, he is serving as
clinical head of the department of cardiovascular medicine at the University Hospital of Leuven and
professor at the faculty of medicine and biomedical sciences of the University of Leuven.
Prof. Dubois has published multiple papers and abstracts in influent peer-reviewed journals as the New
England Journal of Medicine, Journal of the American College of Cardiology, Lancet, European Heart
Journal, International Journal of Cardiology, EuroIntervention, American Journal of Cardiology,
Catheterization and Cardiovascular Interventions and Heart.
Prof. Dubois is Fellow of the European Society of Cardiology and President of the Belgian Working
Group on Interventional Cardiology. He also serves as steering committee member of the European
Structural Heart Diseases Coalition.
